tiprankstipranks
Microsoft (NASDAQ:MSFT) Joins Hands with Novo Nordisk on AI in Drug Discovery
Market News

Microsoft (NASDAQ:MSFT) Joins Hands with Novo Nordisk on AI in Drug Discovery

Microsoft (NASDAQ:MSFT) is collaborating with Denmark’s Novo Nordisk (NASDAQ:NVO) to bring together computational services, cloud, and AI and Novo’s expertise in drug discovery, development, and data science.

The move is aimed at accelerating Novo’s R&D and expanding its AI capabilities. The AI models resulting from this partnership will be used in a number of use cases.

The first two of these use cases- automated summarization and analysis of information and developing models to predict the risk of developing atherosclerosis (a cardiovascular disease)- are already in execution.

Additionally, the platform approach undertaken will enable the collaboration to initiate new projects and use cases on a continuous basis.

Read full Disclosure

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles